Providing a diverse range of perspectives from bullish to bearish, 10 analysts have published ratings on FMC FMC in the last three months.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 3 | 5 | 1 | 0 |
| Last 30D | 0 | 1 | 1 | 0 | 0 |
| 1M Ago | 0 | 1 | 2 | 1 | 0 |
| 2M Ago | 1 | 0 | 1 | 0 | 0 |
| 3M Ago | 0 | 1 | 1 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $64.2, a high estimate of $80.00, and a low estimate of $55.00. Experiencing a 7.35% decline, the current average is now lower than the previous average price target of $69.29.
Decoding Analyst Ratings: A Detailed Look
In examining recent analyst actions, we gain insights into how financial experts perceive FMC. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Laurent Favre | Exane BNP Paribas | Announces | Neutral | $56.00 | - |
| Aleksey Yefremov | Keybanc | Lowers | Overweight | $76.00 | $80.00 |
| Christopher Parkinson | Mizuho | Lowers | Neutral | $55.00 | $59.00 |
| Steve Byrne | B of A Securities | Lowers | Underperform | $57.00 | $60.00 |
| Joshua Spector | UBS | Raises | Neutral | $61.00 | $59.00 |
| Aleksey Yefremov | Keybanc | Lowers | Overweight | $80.00 | $83.00 |
| Brian Wright | Roth MKM | Announces | Buy | $74.00 | - |
| Joel Jackson | BMO Capital | Lowers | Market Perform | $63.00 | $80.00 |
| Arun Viswanathan | RBC Capital | Maintains | Outperform | $61.00 | - |
| Joshua Spector | UBS | Lowers | Neutral | $59.00 | $64.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to FMC. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of FMC compared to the broader market.
- Price Targets: Analysts navigate through adjustments in price targets, providing estimates for FMC's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.
Capture valuable insights into FMC's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on FMC analyst ratings.
Unveiling the Story Behind FMC
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
A Deep Dive into FMC's Financials
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: FMC displayed positive results in 3 months. As of 31 December, 2023, the company achieved a solid revenue growth rate of approximately 16.72%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Materials sector.
Net Margin: FMC's net margin excels beyond industry benchmarks, reaching 95.85%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): FMC's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 28.44% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): FMC's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 9.6% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 0.89, caution is advised due to increased financial risk.
What Are Analyst Ratings?
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
